Trial intelligence / Profile preview

Double-blind randomized placebo-controlled trial of Kytta-Salbe f in painful gonarthrosis

2005-003144-65Phase 3Completed

Sponsor
Merck & Co.
Start
Jul 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Kytta-Salbe f with Placebo (2 arms). Primary endpoints: Pain at rest (VAS) and Pain in motion (VAS). Started Jul 2005; status: completed.

02

Drugs

comfrey root extract
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2005-003144-65.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003144-65.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call